Skip to main content
. 2021 Mar 8;11:576036. doi: 10.3389/fonc.2021.576036

Table 3.

Frequency of treatment-related grade ≥3 adverse events (AE).

Variable cohort A (n = 252) cohort B (n = 298) P-value*
Hematologic toxicities, n (%)
Any 67 (27) 91 (31) 0.355
Neutropenia 50 (20) 63 (21) 0.674
Anemia 13 (5) 33 (11) 0.019
Thrombocytopenia 12 (5) 13 (4) 0.985
Non-hematologic toxicities, n (%)
Any 65 (26) 80 (27) 0.856
Fatigue 3 (1) 12 (4) 0.076
Anorexia 4 (2) 24 (8) 0.001
Febrile neutropenia 3 (1) 6 (2) 0.674
Hand-foot skin reaction 32 (13) 12 (4) <0.001
Liver dysfunction 14 (6) 14 (5) 0.794
*

P-values were calculated by Fisher's exact probability test for categorical variables.

AE, adverse event.